Product Information
SELEGILINE HCL 5 MG CAPSULE is a generic product labeled by Apotex Corp., priced at $0.7563 per EA under NDC 60505005501. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 4, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the SELEGILINE HYDROCHLORIDE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Apotex Corp.NDC
60505005501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SELEGILINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075321FDA Approved
12/4/1998
TE Code
AB
On Market Since
7/15/1997
Pharmacological Classes
Price Statistics
The NADAC for SELEGILINE HCL 5 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 46.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7563 per EA |
|---|---|
| All-time high | $1.5538 (Nov 16, 2016) |
| All-time low | $0.4117 (May 22, 2024) |
| 52-week high | $0.7563 |
| 52-week low | $0.6053 |
| Median price | $1.1170 |
| Average price | $1.0757 |
| Largest weekly change | +51.1% (Nov 22, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SELEGILINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Monoamine Oxidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SELEGILINE HCL 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for SELEGILINE HCL 5 MG CAPSULE, manufactured by Apotex Corp., is $0.7563 per EA (NDC 60505005501), effective Sep 30, 2026.
How has the price of SELEGILINE HCL 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for SELEGILINE HCL 5 MG CAPSULE has declined 46.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SELEGILINE HCL 5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for SELEGILINE HCL 5 MG CAPSULE has ranged from a low of $0.4117 (May 22, 2024) to a high of $1.5538 (Nov 16, 2016), with a median of $1.1170 per EA.
Are there cheaper alternatives to SELEGILINE HCL 5 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SELEGILINE HCL 5 MG CAPSULE, is $0.7307 per EA — about 3% below SELEGILINE HCL 5 MG CAPSULE.
Who manufactures SELEGILINE HCL 5 MG CAPSULE?
SELEGILINE HCL 5 MG CAPSULE (NDC 60505005501) is labeled by Apotex Corp., and CMS classifies it as a generic product.